So Jennifer Y, Lastra Alejandra C, Zhao Huaqing, Marchetti Nathaniel, Criner Gerard J
Division of Pulmonary and Critical Care Medicine, Temple University Hospital, Philadelphia, Pennsylvania.
Chronic Obstr Pulm Dis. 2015 Nov 11;3(1):398-405. doi: 10.15326/jcopdf.3.1.2015.0142.
: Chronic obstructive pulmonary disease, (COPD) is a major cause of morbidity and mortality in the United States. Peak expiratory flow rate (PEFR) monitoring could provide a daily objective measurement of lung function in COPD patients at home. We hypothesized that individuals with greater variability in daily PEFR would signal an unstable patient population with worse outcomes. This was a retrospective analysis of prospectively collected data using an electronic diary to record daily PEFR and symptoms in severe and very severe COPD patients. Rates of PEFR change were used to characterize patients into stable and unstable groups determined by the distribution of slopes. Exacerbation-free days, time to first hospitalization, hospitalization rate, length of hospitalization, and all-cause mortality were assessed. A total of 104 severe and very severe COPD patients met entry criteria, and were observed for 37,702 patient-days. There were no significant differences in baseline symptoms, demographics, forced expiratory volume in 1 second (FEV) or comorbidities between stable versus unstable groups. The unstable group had 34.7 less exacerbation-free days and significantly shorter 6 minute walk distances (6MWD) (227.1 versus 270.7 meters, =0.031), shorter time to first hospitalization (163 versus 286 days, =0.017), more frequent hospitalizations (2.6 versus 1.7 per year, =0.032) and higher all-cause mortality (10.8 versus 5.1%, = 0.04). : Patients with severe to very severe COPD with greater changes in PEFR have shorter 6MWD, reduced time to first hospitalization, more frequent hospitalizations, and higher all-cause mortality despite similar demographic, spirometric and comorbid parameters at baseline. Daily peak flow monitoring can be a useful tool in identifying COPD patients predisposed to worse outcomes.
慢性阻塞性肺疾病(COPD)是美国发病和死亡的主要原因。呼气峰值流速(PEFR)监测可为COPD患者在家中提供每日肺功能的客观测量。我们假设,每日PEFR变异性较大的个体表明患者群体不稳定,预后较差。这是一项对前瞻性收集数据的回顾性分析,使用电子日记记录重度和极重度COPD患者的每日PEFR和症状。PEFR变化率用于根据斜率分布将患者分为稳定组和不稳定组。评估无急性加重天数、首次住院时间、住院率、住院时长和全因死亡率。共有104例重度和极重度COPD患者符合纳入标准,观察了37702个患者日。稳定组和不稳定组在基线症状、人口统计学特征、第1秒用力呼气量(FEV)或合并症方面无显著差异。不稳定组的无急性加重天数少34.7天,6分钟步行距离(6MWD)显著缩短(227.1米对270.7米,P=0.031),首次住院时间缩短(163天对286天,P=0.017),住院更频繁(每年2.6次对1.7次,P=0.032),全因死亡率更高(10.8%对5.1%,P = 0.04)。重度至极重度COPD患者,尽管基线时人口统计学、肺量计和合并症参数相似,但PEFR变化较大者6MWD较短,首次住院时间缩短,住院更频繁,全因死亡率更高。每日峰值流量监测可能是识别易发生较差预后的COPD患者的有用工具。